Stem cell particles tested as lifeline for failing livers
NCT ID NCT07409259
Summary
This early-stage study is testing whether injections of tiny particles called exosomes, derived from stem cells, can help control acute-on-chronic liver failure when added to standard care. The trial will enroll 20 patients with this serious liver condition to compare survival rates and symptom improvement between those receiving the exosome treatment plus standard care versus standard care alone. Researchers will closely monitor safety and whether the treatment helps patients live longer and feel better over 12 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Third Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangdong, China 510630
Guangzhou, Guangdong, 510630, China
Conditions
Explore the condition pages connected to this study.